Despite advances in the fields of prevention, medical intervention and surgical therapy, cardiovascular disease remains a major public healthcare issue. A promising area of research is the potential application of regenerative therapies with pluripotential stem cells to reduce the burden of heart disease and its sequelae. Umbilical cord blood, a rich source of multiple populations of nonembryonic stem cells, will be a valuable resource and has the potential to advance therapeutic options for patients with acquired and congenital heart disease.
Keyphrases
- stem cells
- healthcare
- congenital heart disease
- cord blood
- mesenchymal stem cells
- umbilical cord
- cardiovascular disease
- cardiac surgery
- cell therapy
- randomized controlled trial
- mental health
- acute kidney injury
- type diabetes
- emergency department
- risk assessment
- risk factors
- cardiovascular risk factors
- health information